List of Figures:
Figure 3-1: Clinical Research Outsourcing Market (Million US$), 2009-2015
Figure 3-2: Clinical Trials by Phase (%)
Figure 3-3: Clinical Trials by Therapy (%)
Figure 3-4: Clinical Trials by Funding (%)
Figure 3-5: Number of Global and Local Trials Permitted (2007-2010)
Figure 3-6: Number of Clinical Trials (2007 & 2009)
Figure 4-1: Average Annual Cost for Conducting Clinical Trials in Comparison to US
Figure 4-2: Investigator Cost per Visit in Comparison to US, UK and Singapore
Figure 4-3: Numbers of Clinical Trials Completed on Time in Comparison to UK, US and Germany
Figure 4-4: Time Taken for Conducting Clinical Trials by Phase in Comparison to US (Months)
Figure 4-5: Pharma Outsourcing Market (Billion US$), 2009-2013
Figure 4-6: Pharma Outsourcing Market by Segment (%), 2008
Figure 4-7: IVD Market (Million US$), 2009 & 2012
Figure 5-1: Population (Million), 2009-2013
Figure 5-2: Population Breakup by Age Group (%), 2009-2013
Figure 5-3: New and Total Number of Cancer Patients (‘000)
Figure 5-4: Number of Hypertension Patients (Million), 2009 & 2025
Figure 5-5: Number of Coronary Heart Disease Patients (Million), 2010 & 2015
Figure 5-6: Recruitment Time for Patients Participating in Clinical Trials in Comparison to US (Days)
Figure 5-7: Number of Patient per Site in Comparison to US
Figure 6-1: Annual Supply of Science Graduates and Postgraduates (‘000)
Figure 6-2: Number of Graduates and Postgraduates (Million), 2004
Figure 6-3: Share of Science Doctorates in Total Doctorates (2004)
Figure 6-4: Number of Doctors in Comparison to US and Germany (per ‘000 Population), 2009
Figure 6-5: Demand-Supply Gap in Clinical Research Professionals (Number), 2010
Figure 6-6: Number of GCP Trained Investigators (2002 & 2005)
Figure 6-7: Number of GCP Trained Investigators in Comparison to US
Figure 6-8: Number of Hospital Beds (‘000), 2009-2013
Figure 6-9: Hospital Beds Density of Key Countries (per ‘000 Population), 2010
Figure 6-10: Number of Industry Sponsored Phase II-III Clinical Trial Sites of Key Countries
Figure 11-1: Average Cost per Patient for Conducting Clinical Trials in Comparison to UK, US and Germany (US$)
Figure 11-2: Average Cost per Patient for Conducting Phase I Clinical Trials in Comparison to UK, US and Germany (US$)
Figure 11-3: Average Cost per Patient for Conducting Phase II Clinical Trials in Comparison to UK, US and Germany (US$)
Figure 11-4: Annual Cost of Office Space for Conducting Phase II Clinical Trials in Comparison to UK, US and Germany (US$)
Figure 11-5: Average Cost per Patient for Conducting Phase III Clinical Trials in Comparison to UK, US and Germany (US$)
Figure 11-6: Annual Cost of Office Space for Conducting Phase III Clinical Trials in Comparison to UK, US and Germany (US$)
Figure 11-7: Average Cost per Patient for Conducting Phase IV Clinical Trials in Comparison to UK, US and Germany (US$)
Figure 11-8: Annual Cost of Office Space for Conducting Phase IV Clinical Trials in Comparison to UK, US and Germany (US$)
List of Tables:
Table 3-1: Details of State-wise Clinical Trials (January-July 2011)
Table 4-1: Features of Clinical Trials in Comparison to US
Table 5-1: Number of Deaths due to Leading Causes in Middle Income Countries (Million)
Table 5-2: Number of Diabetic Patients in Age Group 20-79 (‘000), 2010
Table 5-3: Forecast for Number of Diabetic Patients in Age Group 20-79 (‘000), 2030
Table 5-4: New Cancers Incidences (per ‘00,000 Females), 2005
Table 5-5: New Cancers Incidences (per ‘00,000 Males), 2005
Table 5-6: Obesity Statistics (2009)
Table 6-1: Structure of Medical Education
Table 6-2: Number of GLA Approved Facilities by Type
Table 9-1: Regulatory Bodies Involved in Pharmaceutical Regulation
Table 9-2: Regulatory Timelines for Conducting Clinical Trials
Table 11-1: Average Cost of Clinical Research in Comparison to US by Phase (Million US$)
Table 11-2: Calculation of Clinical Trials Costs Savings in Comparison to US
Table 11-3: Annual Cost of Staff for Conducting Phase I Clinical Trials in Comparison to UK, US and Germany (US$)
Table 11-4: Annual Cost of Utility for Conducting Phase I Clinical Trials in Comparison to UK, US and Germany (US$)
Table 11-5: Annual Cost of Staff for Conducting Phase II Clinical Trials in Comparison to UK, US and Germany (US$)
Table 11-6: Annual Cost of Utility for Conducting Phase II Clinical Trials in Comparison to UK, US and Germany (US$)
Table 11-7: Annual Cost of Staff for Conducting Phase III Clinical Trials in Comparison to UK, US and Germany (US$)
Table 11-8: Annual Cost of Utility for Conducting Phase III Clinical Trials in Comparison to UK, US and Germany (US$)
Table 11-9: Annual Cost of Staff for Conducting Phase IV Clinical Trials in Comparison to UK, US and Germany (US$)
Table 11-10: Annual Cost of Utility for Conducting Phase IV Clinical Trials in Comparison to UK, US and Germany (US$)
